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Background: Early diagnosis and treatment of nontuberculous mycobacterial lung diseases (NTM-LD) and pulmonary
tuberculosis (PTB) are important clinical issues. The present study aimed to compare and identify the chest CT characteristics
that help to distinguish NTM lung disease from PTB in patients with acid-fast bacilli (AFB) smear-positive sputum.
Methods: From January 2009 to April 2012, we received 467 AFB smear-positive sputum specimens. A total of 95 CT scans
obtained from the 159 patients were analyzed, 75 scans were from patients with PTB and 20 scans from NTM-LD. The typical
chest CT findings of mycobacterial diseases were analyzed.
Results: In patients with PTB, the prevalence of pleural effusion (38.7% vs. 15.0%; P =0.047), nodules < 10 mm in size (76.0%
vs. 25.0%; P< 0.001), tree-in-bud pattern (81.3% vs. 55.0%; P =0.021), and cavities (31.1% vs. 5.0%; P =0.018) were significantly
higher than patients with NTM. Of the 20 patients with NTM lung diseases, bronchiectasis and cystic changes were
significantly higher than patients with PTB (20.0% vs. 4.0%; P = 0.034). In multivariate analysis, CT scan findings of
nodules was independently associated with patients with diagnoses of PTB (odds ratio [OR], 0.07; 95% confidence
interval [CI], 0.02-0.30). Presence of bronchiectasis and cystic changes in CT scans was strongly associated with patients
with NTM-LD (OR, 33.04; 95% CI, 3.01-362.55).
Conclusions: The CT distinction between NTM-LD and PTB may help radiologists and physicians to know the most
likely diagnoses in AFB-smear positive patients and avoid unnecessary adverse effects and the related costs of anti-TB
drugs in endemic areas.
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The diagnosis and treatment of pulmonary diseases
caused by mycobacterial infections are very important
clinical issues. Among mycobacterial diseases, pulmonary
tuberculosis (PTB) is the major entity and one of the
world’s leading infectious diseases. In 2012, 8.6 million* Correspondence: 11319@ymuh.ym.edu.tw
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reproduction in any medium, provided the orpeople felt ill with TB and 1.3 million died from TB [1].
Isolation of Mycobacterium tuberculosis from respiratory
specimens is recommended for the definite diagnosis of
PTB [2]. Microscopic examination of sputum smears for
acid-fast bacilli (AFB) is widely used and the most efficient
procedure for the initial screening of PTB. The presence
of AFB in the stained sputum (AFB smear-positive) indi-
cates a preliminary diagnosis of pulmonary mycobacterial
infection. However, positive AFB smear test is not specific
for PTB [3-5]. AFB smear-positive sputum may represent
mycobacterium tuberculosis, but it can also represent
non-tuberculous mycobacteria (NTM) [6]. NTM ared. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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and clinical symptoms changes slowly as compared with
PTB [7]. In endemic areas, it is not uncommon to admin-
ister empirical anti-TB drugs in clinically suspected PTB
patients with AFB smear-positive sputum. The isolation
prevalence of NTM has increased gradually, which raise
the concerns of unnecessary adverse effect and costs of
anti-TB drugs [8,9]. Therefore, additional diagnostic tools
that help differentiate PTB and NTM is relevant in
patients pending culture results. Radiological manifesta-
tions such as computed tomography (CT) features are
useful to aid the diagnosis of PTB and NTM before defin-
ite mycobacterial culture because of its great availability
and short examination time [10]. The aim of this study is
to compare and identify the chest CT characteristics that
help to distinguish NTM lung disease from PTB in
patients with AFB smear-positive sputum.Methods
Patients
From January 2009 to April 2012, we received 9,267
sputum specimens from 3,958 patients at the laboratory
of National Yang-Ming University Hospital (a 512-bed
regional teaching hospital in Yilan, Taiwan) and the Far
Eastern Memorial Hospital (a 1050-bed tertiary medical
center in Taipei, Taiwan). Of these sputum specimens,
467 from 236 patients were AFB stain-positive. Only 134
of the AFB stain-positive patients had proven pulmonary
TB, and 25 patients proven NTM lung diseases. A total
of 95 CT scans obtained from the 159 patients were
analyzed, 75 scans were from patients with PTB and 20
scans from NTM lung disease. The study was approved
by the Institutional Review Boards of the National Yang-
Ming University Hospital and the Far Eastern Memorial
Hospital. All participants gave written informed consent
and agree of information collection in the study. All
images of the participants were taken as part of standard
patient care.Table 1 Clinical characteristics of patients with pulmonary tu
Pulmonary tuberculosis n = 75
Age, years 65.57 ± 18.20
Male 58 (77.3)
Ever smoker 24 (32.0)
Diabetes mellitus 14 (18.7)
Malignancy 3 (4.0)
Autoimmune disease 2 (2.7)
COPD 9 (12.0)
Pneumoconiosis 1 (1.3)
Numbers in parentheses are percentages. NTM: non-tuberculosis mycobacterium; CDiagnosis of pulmonary TB and NTM
All of the sputum specimens were treated with Ziehl-
Neelsen staining. TB polymerase chain reaction (PCR)
was performed with in-house IS6110-based PCR assays
[11]. Mycobacterial cultures were performed using
Löwenstein-Jensen medium [12]. Patients were diagnosed
with pulmonary TB if M. tuberculosis was isolated from
their sputum or tissue specimens. NTM was diagnosed
according to mycobacterial cultures and the American
Thoracic Society (ATS) guideline [13].
CT scanning methods
The CT scans were original films obtained from each in-
stitution. All CT examinations were performed within
3 months of AFB smear test. Conventional CT scans were
performed with a 5 mm slice-thickness at 5 mm intervals
by using multi-detector CT (Philips Brilliance 64). HRCT
images were obtained with a 1 mm slice-thickness at
10 mm intervals. Scanning extended from the lung apices
to below the costophrenic angles at maximum inspiration.
The CT scans were reviewed independently by two experi-
enced radiologists and pulmonary specialists blinded to the
patient’s microbiology results. The final decisions regarding
the findings were determined by consensus.
Statistical analysis
All statistical analyses were conducted using SPSS soft-
ware for Windows (v 20; IBM Corporation, Armonk, NY,
USA). Data are presented as frequencies for categorical
variables, and by mean ± standard deviation for numerical
variables. Categorical variables were compared using a
chi-square test or Fisher’s exact test, and continuous
variables were compared using an independent unpaired
t-test. Univariate analysis was performed to evaluate the
characteristic CT findings. Multivariate analysis was
conducted using a logistic regression model to determine
the independent predictive factors for patients with PTB
and NTM infections. P-values of less than 0.05 were
considered to be significant.berculosis and NTM lung diseases
NTM lung disease n = 20 P value








OPD: chronic obstructive pulmonary disease.
Figure 2 High resolution CT with 1 mm slice-thickness of a 92 –
year-old female with NTM (Mycobacterium avium complex) lung
disease demonstrating the bronchiectasis and cystic changes at
left upper and lower lobes and at right lower lobe.
Yuan et al. BMC Pulmonary Medicine 2014, 14:65 Page 3 of 6
http://www.biomedcentral.com/1471-2466/14/65Results
The 75 patients with PTB included 58 men and 17 women
with a mean age ± standard deviation of 65.6 years ±18.2
(range, 23–86 years). The 20 patients with NTM included
11 men and 9 women with a mean age ± standard devi-
ation of 67.6 years ±14.6 (range, 30–92 years). The clinical
data are summarized in Table 1. The CT findings were
classified as presence or absence of pleural effusion, cavity
formation, atelactasis, consolidation, nodules less than
10 mm in size, tree-in-bud pattern (branching centrilobu-
lar nodules), interlobular septal thickening, lung volume
reduction, bronchiectasis, lymphadenopathy, calcified
lymph nodes, as well as bronchiectasis and cystic changes.
Of the 75 patients with PTB, 29 (38.7%) had pleural
effusion vs. 3 (15.0%) in patients with NTM (P =0.047). 57
(76.0%) patients with PTB had nodules vs. 5 (25.0%)
patients with NTM (P < 0.001). 61 (81.3%) patients with
PTB had tree-in-bud opacities vs. 11 (55.0%) patients
with NTM (P =0.021) (Figure 1). And 23 (31.1%) pa-
tients with PTB had cavities vs. 1 (5.0%) patient with
NTM (P =0.018). Consalidation, lymphadenopathy and
calcified lymph nodes were also more common in PTB
patients. Of the 20 patients with NTM lung diseases, 4
(20.0%) had bronchiectasis and cystic changes vs. 3 (4.0%)
patients with PTB; (P = 0.034) (Figures 2 and 3). Atelactasis,
bronchiectasis without cystic changes and lung paren-
chymal volume reduction were more common in NTM
lung diseases, but the univariate statistical results were
not significant (Table 2). In multivariate analysis, CT
scan findings of nodules was independently associated
with patients with diagnoses of PTB (odds ratio [OR],
0.07; 95% confidence interval [CI], 0.02-0.30). Presence
of bronchiectasis and cystic changes in CT scans wasFigure 1 Thin section CT of a 72–year-old male with pulmonary
tuberculosis demonstrating nodules (arrows) and tree-in-bud
pattern (arrowhead); loculated pleural effusion at right lower
lung zones.strongly associated with patients with NTM lung dis-
eases (OR, 33.04; 95% CI, 3.01-362.55) (Table 3).
Discussion
The present study shows that chest CT findings could
help to differentiate pulmonary TB from NTM lung
diseases. Upon comparing CT features between PTB and
NTM, pleural effusion, nodules are significantly more
common in patients with PTB and bronchiectasis com-
bined with cystic changes are significantly more common
in patients with NTM infections. In multivariate analysis,
presence of nodules is significantly associated with PTB,
and bronchiectasis combined with cystic changes are
strongly associated with NTM lung diseases.
The definite diagnosis of PTB still depends on PCR or
mycobacterial culture from bronchial washing or sputum.Figure 3 Thin section CT of an 86 –year-old male with NTM
(Mycobacterium avium complex) lung disease demonstrating
the bronchiectasis and cystic changes at left upper lobe.
Table 2 Comparative chest CT findings of non-tuberculous mycobacterial lung diseases and pulmonary tuberculosis
Pulmonary tuberculosis n = 75 NTM lung diseases n = 20 P value
Chest CT findings
Pleural effusion 29 (38.7) 3 (15.0) 0.047
Cavities 23 (31.1) 1 (5.0) 0.018
Atelectasis 41 (54.7) 12 (60.0) 0.670
Consolidation 41 (54.7) 9 (45.0) 0.442
Random nodules 57 (76.0) 5 (25.0) <0.001
Interlobular septal thickening 67 (89.3) 17 (85.0) 0.694
Bronchiectasis 10 (13.3) 4 (20.0) 0.484
Lung volume reduction 7 (9.3) 4 (20.0) 0.236
Tree-in-bud pattern 61 (81.3) 11 (55.0) 0.021
Lymphadenopathy 18 (24.0) 1 (5.0) 0.066
Calcified lymph nodes 5 (6.7) 0 (0.0) 0.580
Bronchiectasis and cystic changes 3 (4.0) 4 (20.0) 0.034
Numbers in parentheses are percentages. NTM = non-tuberculous mycobacterium.
CT = computed tomography.
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ant role in the diagnosis of TB. Typical radiological features
of pulmonary TB include parenchymal diseases such as
consolidation and cavities; pleural effusion, variable-
sized nodules and lymphadenopathy are well documented
and repeatedly reviewed in literatures. The CT findings in
our study are mostly identical to the previously reported
radiological findings of PTB. Familiar thin-section chest
CT findings of nontuberculous mycobacterial infection
include bronchiectasis, small and large nodules, centrilobu-
lar nodules, consolidation and fibrocavitary lesions [14,15].
Our study also demonstrates the common radiographic
findings of bronchiectasis, tree-in-bud pattern, atelactasis
and consolidation in patients with NTM lung diseases, but
there are no significant differences as compared with the
PTB patients. To our knowledge, the CT finding of bron-
chiectasis and cystic changes in NTM infection has not
been emphasized in the previous studies. Although the
radiological evidence of severe bronchiectasis and subse-
quent cystic changes, which is traditionally described as
the honeycomb appearance, usually represents end-stage
interstitial fibrosis, it is reported to be a dynamic process
and may have different evolution [16,17]. In order to
exclude the pre-existing bronchiectasis and cystic changes,
the previous films of the four patients with NTM lung
diseases demonstrating bronchiectasis and cystic changesTable 3 Multivariate analysis of predictors for NTM lung dise
CT findings Odds ratio
Bronchiectasis and cystic changes 33.035
Pleural effusion 0.198
Random nodules 0.074
CI = confidence interval; PTB = pulmonary tuberculosis; NTM = nontuberculous mycowere reviewed since the PACS implementation in our in-
stitutions from March 2004. Regarding the diagnosis of
NTM, the isolation of NTM species from a respiratory
sample is an insufficient evidence for the definite diagnosis
of NTM lung disease. Some patients with positive NTM
culture do not have evidences of pulmonary disease, and
such infection may indicate colonization or transient infec-
tion. Therefore, the ATS issued diagnostic criteria for
NTM lung diseases which not only rely on microbiological
examinations, the clinical and radiographic evidences are
also essential. Clinical researches have shown that disease
attributable to NTM has a rising trend in many developed
and developing countries [18,19]. In endemic areas, imme-
diate and empirical treatment of mycobacterial diseases
based on the result of AFB sputum smear has an important
impact on disease transmission control. However, the
administration of unnecessary empiric anti-TB treatment is
not uncommon in real world practice and patients might
suffer from the adverse effects of anti-TB drugs. Our
colleagues (Shih-Chieh Chang, et al.) issued an article that
revealed 40.4% of patients with positive sputum AFB stains
did not have pulmonary TB in Taiwan [20]. According to
Chang’s results, among patients who had positive sputum
AFB stains without pulmonary TB, 25.8% were prescribed
anti-TB treatment and 44% of them developed various
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did cause unnecessary harm. Our study provides radio-
graphic evidence that chest CT finding of the bronchiec-
tasis and cystic changes is statistically a strong indicator of
NTM disease in patients with AFB smear-positive sputum.
This characteristic CT feature is helpful to distinguish
NTM from PTB in patients with equivocal clinical symp-
toms and pending culture results. Considering our results,
physicians can make more precise decisions to initiate
empiric anti-TB treatment and avoid unnecessary ad-
verse effects on patients with final diagnoses of NTM
lung diseases.
Our study had several limitations that are worth noting.
Not all the AFB smear-positive patients with NTM lung
diseases underwent chest CT. It was likely that the study
was biased toward patients with severe infection who war-
ranted further CT scans evaluation. In all cases, CT scans
were obtained within 3 months of AFB smear tests. Some
AFB smear-positive patients had received empirical anti-
TB drugs. The CT findings in patients with actual PTB
diagnoses might show improvement and somewhat not
identical to the typical features of pulmonary TB. Finally,
although there was a strong association of random nodules
in PTB as well as bronchiectasis and cystic changes in
NTM-LD statistically, the conclusions drawn by our statis-
tical results needed a large-scale analysis to be confirmed.Conclusions
Our results suggest that pulmonary tuberculosis and
NTM lung diseases can usually be distinguished by asses-
sing the CT findings of nodules in patients with PTB as
well as bronchiectasis and cystic changes with NTM. The
CT distinction between these two mycobacterial infec-
tions may help radiologists and physicians to know the
most likely diagnoses in AFB-smear positive patients and
avoid unnecessary adverse effects and costs of anti-TB
drugs in endemic areas.Competing interests
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